BML264

• Description:

  BML264 ((E) -N- (p-amylcinnamoyl) anthranilic acid) is an agonist for TREK-1. BML264 can be used to study diseases associated with TASK1 dysfunction[1].

• Product Name Alternative:

  (E) -N- (p-Amylcinnamoyl) anthranilic acid; (E) -ACA

• UNSPSC:

  12352005

• Hazard Statement:

  H410

• Target:

  Potassium Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/bml264.html

• Smiles:

  O=C(O)C1=CC=CC=C1NC(/C=C/C2=CC=C(CCCCC)C=C2)=O

• Molecular Formula:

  C21H23NO3

• Molecular Weight:

  337.41

• Precautions:

  P273-P391-P501

• References & Citations:

  [1]Feinmark S, et al., Method of treating a condition associated with phosphorylation of TASK-1. US20070259051 A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [99196-74-4]